| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Neeraj Lalwani | Q55908334 |
| P2093 | author name string | Phyllis C Huettner | |
| Srinivasa R Prasad | |||
| Raghunandan Vikram | |||
| Najla Fasih | |||
| Alampady K Shanbhogue | |||
| P433 | issue | 3 | |
| P921 | main subject | ovarian cancer | Q172341 |
| diagnosis | Q16644043 | ||
| P304 | page(s) | 625-646 | |
| P577 | publication date | 2011-05-01 | |
| P1433 | published in | RadioGraphics | Q15755459 |
| P1476 | title | Histologic, molecular, and cytogenetic features of ovarian cancers: implications for diagnosis and treatment | |
| P478 | volume | 31 |
| Q36380704 | 'BRCAness' and its implications for platinum action in gynecologic cancer |
| Q36790208 | A Case of Stage III c Ovarian Clear Cell Carcinoma: The Role for Predictive Biomarkers and Targeted Therapies |
| Q36413189 | A long noncoding RNA AB073614 promotes tumorigenesis and predicts poor prognosis in ovarian cancer |
| Q50125499 | A systematic approach to adnexal masses discovered on ultrasound: the ADNEx MR scoring system. |
| Q46238472 | ADAM9 is over-expressed in human ovarian clear cell carcinomas and suppresses cisplatin-induced cell death |
| Q50896543 | ATR-FTIR spectroscopy coupled with chemometric analysis discriminates normal, borderline and malignant ovarian tissue: classifying subtypes of human cancer. |
| Q55347140 | Bilateral Ovarian Tumors on MRI: How Should We Differentiate the Lesions? |
| Q90452178 | Can Stemness and Chemoresistance Be Therapeutically Targeted via Signaling Pathways in Ovarian Cancer? |
| Q28073246 | Chemoresistance and targeted therapies in ovarian and endometrial cancers |
| Q37042308 | Clinicopathological correlates and prognostic significance of KRAS mutation status in a pooled prospective cohort of epithelial ovarian cancer |
| Q36335591 | Comparison between types I and II epithelial ovarian cancer using histogram analysis of monoexponential, biexponential, and stretched-exponential diffusion models. |
| Q92524988 | Cytological sampling of fallopian tubes using a hysteroscopic catheter: A multi-center study |
| Q36444552 | Diagnostic accuracy of diffusion-weighted imaging with conventional MR imaging for differentiating complex solid and cystic ovarian tumors at 1.5T |
| Q36059087 | Do hereditary syndrome-related gynecologic cancers have any specific features? |
| Q39064092 | Ets-1 regulates its target genes mainly by DNA methylation in human ovarian cancer |
| Q58921526 | Gold(iii) complexes inhibit growth of cisplatin-resistant ovarian cancer in association with upregulation of proapoptotic PMS2 gene |
| Q38719149 | Hyperthermic intraperitoneal chemoperfusion as a component of multimodality therapy for ovarian and primary peritoneal cancer. |
| Q35184824 | Hypodontia phenotype in patients with epithelial ovarian cancer |
| Q35172301 | Immunohistological insight into the correlation between neuropilin-1 and epithelial-mesenchymal transition markers in epithelial ovarian cancer |
| Q33553490 | Long noncoding RNA NBAT-1 suppresses tumorigenesis and predicts favorable prognosis in ovarian cancer |
| Q49415848 | Long noncoding RNA lncBRM facilitates the proliferation, migration and invasion of ovarian cancer cells via upregulation of Sox4. |
| Q36510666 | MR imaging of ovarian masses: classification and differential diagnosis |
| Q35575822 | MRI for differentiating ovarian endometrioid adenocarcinoma from high-grade serous adenocarcinoma |
| Q26751352 | MRI of endometrium cancer - how we do it |
| Q35687723 | Magnetic Resonance Imaging Characteristics of Ovarian Clear Cell Carcinoma |
| Q93050559 | Magnetic resonance imaging in categorization of ovarian epithelial cancer and survival analysis with focus on apparent diffusion coefficient value: correlation with Ki-67 expression and serum cancer antigen-125 level |
| Q38170877 | Mismatch repair deficiency in ovarian cancer -- molecular characteristics and clinical implications |
| Q52678656 | Mismatch repair deficiency is associated with MSI phenotype, increased tumor-infiltrating lymphocytes and PD-L1 expression in immune cells in ovarian cancer. |
| Q36012760 | Mucinous adenocarcinoma developed from human fallopian tube epithelial cells through defined genetic modifications |
| Q36800356 | Mucinous borderline tumor involving fallopian tube: case report and review of the literature |
| Q30455378 | Non-invasive diagnosis of abdomino-pelvic masses: role of multimodality imaging |
| Q92409206 | Novel Approaches in Ovarian Cancer Research against Heterogeneity, Late Diagnosis, Drug Resistance, and Transcoelomic Metastases |
| Q35871283 | Novel biomarker candidates for the diagnosis of ovarian clear cell carcinoma |
| Q58763140 | Outcomes of Non-High Grade Serous Carcinoma after Neoadjuvant Chemotherapy for Advanced-Stage Ovarian Cancer: Single-Institution Experience |
| Q90400040 | Ovarian Cancer, Cancer Stem Cells and Current Treatment Strategies: A Potential Role of Magmas in the Current Treatment Methods |
| Q90480539 | Pharmacokinetic evaluation and antitumor potency of liposomal nanoparticle encapsulated cisplatin targeted to CD24-positive cells in ovarian cancer |
| Q36589159 | Poly(ethylene glycol)-block-poly(ε-caprolactone) micelles for combination drug delivery: evaluation of paclitaxel, cyclopamine and gossypol in intraperitoneal xenograft models of ovarian cancer |
| Q27319594 | Polymeric micelles for apoptosis-targeted optical imaging of cancer and intraoperative surgical guidance |
| Q35061331 | Prognostic relevance of acquired uniparental disomy in serous ovarian cancer |
| Q36294598 | Proteomic Analysis of Matched Formalin-Fixed, Paraffin-Embedded Specimens in Patients with Advanced Serous Ovarian Carcinoma |
| Q34371477 | REDD1 and p-AKT over-expression may predict poor prognosis in ovarian cancer |
| Q38676869 | Revised FIGO staging system for cancer of the ovary, fallopian tube, and peritoneum: important implications for radiologists |
| Q38884652 | Significance of MNK1 in prognostic prediction and chemotherapy development of epithelial ovarian cancer |
| Q52886475 | Synchronous Endometrial and Ovarian Carcinomas: Evidence of Clonality. |
| Q50107365 | Targeting estrogen receptor beta (ERβ) for treatment of ovarian cancer: importance of KDM6B and SIRT1 for ERβ expression and functionality |
| Q26750610 | Update on Imaging of Ovarian Cancer |
| Q91828723 | Upregulated LINC00565 Accelerates Ovarian Cancer Progression By Targeting GAS6 |
| Q89546139 | Upregulation of hsa_circ_0007874 suppresses the progression of ovarian cancer by regulating the miR-760/SOCS3 pathway |
Search more.